The global nutraceutical contract manufacturing services market is poised to attain remarkable growth from 2023 to 2033. According to the research report published by FMI, the global market is anticipated to surpass a valuation of US$ 149.41 billion in 2023. It is likely to reach a valuation of US$ 466.11 billion by 2033. The market is projected to exhibit an astonishing CAGR of 12.05% from 2023 to 2033. The increasing demand for personalized nutrition is expected to foster market development. Additionally, the growing heath consciousness is predicted to aid market expansion.
The demand for nutraceutical products is consistently rising. The awareness concerning the benefits of nutraceuticals consumption has significantly grown in recent years. The increasing urbanization and the rising expenditure on health-related products is expected to aid market development. Furthermore, the increasing prevalence of obesity, cardiovascular, and other chronic diseases is giving a push nutraceutical industry. The growing demand for functional foods and nutraceutical supplements is expected to drive market growth.
Technological advancements in the healthcare industry are rising. The availability of advanced technologies is creating ample growth opportunities for market players. The nutraceutical industry is anticipated to gain more benefits from contract manufacturing services during the forecast period. Factors such as improved shipping options, extensive lab testing, and decreased overhead costs are expected to benefit the industry. Additionally, the economic production and better reliability factors are anticipated to aid market development.
The increasing demand nutraceuticals has led manufacturers to develop and launch newer types of products. Manufacturers are launching products in a myriad of sizes, shapes, and flavors. Soft gels, jellies, and gummies are a few kinds of nutraceutical products gaining popularity. They are also liked by kids, which creates opportunities for manufacturers to engage in products for young kids. Additionally, gummies and jellies are also preferred by the geriatric population, which is a huge target population.
The increasing chronic diseases among female population is driving the development of new nutraceuticals. Manufacturers are developing functional nutraceutical foods and beverages to address women in specific life stages. The evolving landscape of nutraceuticals for women is predicted to create new growth avenues. For instance, WellSource Nutraceuticals launched a nutritional supplement in May 2020. The new supplement was developed for women in fertility programs.
| Attributes | Details |
|---|---|
| Nutraceutical Contract Manufacturing Services Market Share (2022) | US$ 133.34 billion |
| Nutraceutical Contract Manufacturing Services Market (2023) | US$ 149.41 billion |
| Nutraceutical Contract Manufacturing Services Market (2033) | US$ 466.11 billion |
| Nutraceutical Contract Manufacturing Services Market (2023 to 2033) | 12.05% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
According to the report published on nutraceutical contract manufacturing services market, the deployment of these services is rising every year. In 2018, the global market size stood at nearly US$ 84.59 billion. In the following years from 2018 to 2022, the market showcased remarkable growth, accounting for a worth of US$ 133.34 billion.
The increasing chronic diseases and expanding geriatric population are expected to the key factors driving market growth. The growing demand for nutraceuticals by the geriatric population is accelerating market expansion. Furthermore, the demand for customized medicine is rising. Due to the increasing prevalence of chronic diseases, experts are formulating medicine that give the best results on consumption. The growing awareness for herbal and organic nutraceuticals is expected to increase nutraceutical contract manufacturing services adoption.
The adoption of innovative production strategies is anticipated to create growth avenues for market players. Additionally, the expansion of production capabilities is predicted to uptick market expansion. For instance, Star Combo Pharma announced its facility expansion in June 2022. The renowned distributer and manufacturer of nutritional, beauty, and health products inaugurated their new manufacturing facility in New South Wales, Australia.
Functional Foods and Beverages Segment to Register a Noteworthy CAGR
According to the segmentation based on product type, the market is bifurcated into functional foods & beverages, and dietary supplements. The functional food and beverages segment is predicted to register a remarkable CAGR of 12.2% from 2023 to 2033. Functional foods and beverages serve several health advantages. The growing awareness for these advantages is anticipated to fuel their consumption in coming years. The rising demand is anticipated to increase contract manufacturing services in nutraceutical industry.
The coronavirus pandemic gave a significant push to the consumption of functional beverages and foods. Nations such as India, Japan, China, and South Korea have witnessed an increased consumption of functional foods post-pandemic.
Tablets Segment to Retain Dominance in Global Market
According to the segmentation based on dosage type, the market is classified into powder in sachet/jar, energy bars, gummies, liquid oral, capsules, and tablets. Among these, the tablets segment is anticipated to garner prominent revenues in the global market. The dominance of this segment can be attributed to several factors. Tablets are easy to manufacture and have a long shelf life. They can be customized using different sizes, shapes, and coatings according to requirement. Hence, launches of nutraceutical tablets is anticipated to aid market development. In November 2021, Nature’s Sunshine Products collaborated with Nutraceutical Sciences Institute to launch a new line of immunity-supporting supplements. The new range comprises elderberry pills and candies.
Principal Consultant
Asia Pacific generated revenues greater than any region in 2022. The region accounted for more than 40% global market share in 2022. The robust demand from nations such as Australia, South Korea, India, and Japan is attributable to this growth. The improving healthcare infrastructure in these nations is resulting in increased demand for nutraceuticals. The numbers of nutraceutical contract manufacturing service providers are rising in these, fostering market development. The growing consciousness for healthy lifestyles and improving income levels support market development.
The presence of renowned manufacturers in Asia Pacific is likely to contribute to market growth. Players such as Gemini Pharmaceuticals, NUTRIVO, and Ashland comprise in Asia Pacific. The innovative strategies adopted by these players is predicted to boost market development in the region.
The healthcare industry in the United States is mature and advance. It is anticipated to hold a significant share in the market. The increasing prevalence of chronic diseases and expanding food and beverage industry are expected to flourish in market growth. Additionally, the rising acquisitions and collaborations among market players are anticipated to bolster market development. For instance, in August 2021, First Choice ingredients was acquired by Royal DSM. The acquisition is aimed to fulfil the region’s unmet medical requirements. The acquisition is likely to boost economic development and increase scientific research.
The nutraceutical contract manufacturing services market is fairly fragmented. The market comprises players that operate at regional and international levels. The market players are trying to penetrate new territories by forming new partnerships and acquiring businesses. They are emphasizing on expanding their distribution channels with agreements through nutraceutical contract manufacturing services.
The rising use of contemporary technologies and the expanding healthcare infrastructure are expected to create new investment pockets for market players. The launch of nutraceutical using advanced production methods is anticipated to boost positions of market players. Strategic alliances are expected to bode well for market players. Furthermore, more product approvals are expected to bode well for market players.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
China is expected to drive the regional market with a 4.4% CAGR.
The market is valued at US$ 149.41 billion in 2023.
The global adoption of such services was progressed at 12.05% in 2022.
Ashland, Glanbia, and Biotrex are the top service providers in current years.
The region accounted for more than 40% of the global market share in 2022.
1. Executive Summary | Nutraceutical Contract Manufacturing Services Market 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022 4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Dosage Form 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Dosage Form, 2018 to 2022 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Dosage Form, 2023 to 2033 5.3.1. Tablets 5.3.2. Capsules 5.3.3. Liquid Oral 5.3.4. Gummies 5.3.5. Energy Bars 5.3.6. Other suitable forms 5.4. Y-o-Y Growth Trend Analysis By Dosage Form, 2018 to 2022 5.5. Absolute $ Opportunity Analysis By Dosage Form, 2023 to 2033 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By Product, 2018 to 2022 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product, 2023 to 2033 6.3.1. Dietary Supplements 6.3.1.1. Proteins & Amino Acids Supplement 6.3.1.2. Weight Management and Meal Replacer Supplement 6.3.1.3. Multivitamin, Multi-Mineral, and Antioxidant Supplement 6.3.1.4. Other Supplements 6.3.2. Functional Food and Beverages 6.4. Y-o-Y Growth Trend Analysis By Product, 2018 to 2022 6.5. Absolute $ Opportunity Analysis By Product, 2023 to 2033 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 7.1. Introduction 7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022 7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033 7.3.1. North America 7.3.2. Latin America 7.3.3. Europe 7.3.4. South Asia 7.3.5. East Asia 7.3.6. Oceania 7.3.7. MEA 7.4. Market Attractiveness Analysis By Region 8. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 8.2.1. By Country 8.2.1.1. The USA 8.2.1.2. Canada 8.2.2. By Dosage Form 8.2.3. By Product 8.3. Market Attractiveness Analysis 8.3.1. By Country 8.3.2. By Dosage Form 8.3.3. By Product 8.4. Key Takeaways 9. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 9.2.1. By Country 9.2.1.1. Brazil 9.2.1.2. Mexico 9.2.1.3. Rest of Latin America 9.2.2. By Dosage Form 9.2.3. By Product 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Dosage Form 9.3.3. By Product 9.4. Key Takeaways 10. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. Germany 10.2.1.2. United Kingdom 10.2.1.3. France 10.2.1.4. Spain 10.2.1.5. Italy 10.2.1.6. Rest of Europe 10.2.2. By Dosage Form 10.2.3. By Product 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Dosage Form 10.3.3. By Product 10.4. Key Takeaways 11. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. India 11.2.1.2. Malaysia 11.2.1.3. Singapore 11.2.1.4. Thailand 11.2.1.5. Rest of South Asia 11.2.2. By Dosage Form 11.2.3. By Product 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Dosage Form 11.3.3. By Product 11.4. Key Takeaways 12. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. China 12.2.1.2. Japan 12.2.1.3. South Korea 12.2.2. By Dosage Form 12.2.3. By Product 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Dosage Form 12.3.3. By Product 12.4. Key Takeaways 13. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. Australia 13.2.1.2. New Zealand 13.2.2. By Dosage Form 13.2.3. By Product 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Dosage Form 13.3.3. By Product 13.4. Key Takeaways 14. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Country 14.2.1.1. GCC Countries 14.2.1.2. South Africa 14.2.1.3. Israel 14.2.1.4. Rest of MEA 14.2.2. By Dosage Form 14.2.3. By Product 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Dosage Form 14.3.3. By Product 14.4. Key Takeaways 15. Key Countries Market Analysis 15.1. USA 15.1.1. Pricing Analysis 15.1.2. Market Share Analysis, 2022 15.1.2.1. By Dosage Form 15.1.2.2. By Product 15.2. Canada 15.2.1. Pricing Analysis 15.2.2. Market Share Analysis, 2022 15.2.2.1. By Dosage Form 15.2.2.2. By Product 15.3. Brazil 15.3.1. Pricing Analysis 15.3.2. Market Share Analysis, 2022 15.3.2.1. By Dosage Form 15.3.2.2. By Product 15.4. Mexico 15.4.1. Pricing Analysis 15.4.2. Market Share Analysis, 2022 15.4.2.1. By Dosage Form 15.4.2.2. By Product 15.5. Germany 15.5.1. Pricing Analysis 15.5.2. Market Share Analysis, 2022 15.5.2.1. By Dosage Form 15.5.2.2. By Product 15.6. United Kingdom 15.6.1. Pricing Analysis 15.6.2. Market Share Analysis, 2022 15.6.2.1. By Dosage Form 15.6.2.2. By Product 15.7. France 15.7.1. Pricing Analysis 15.7.2. Market Share Analysis, 2022 15.7.2.1. By Dosage Form 15.7.2.2. By Product 15.8. Spain 15.8.1. Pricing Analysis 15.8.2. Market Share Analysis, 2022 15.8.2.1. By Dosage Form 15.8.2.2. By Product 15.9. Italy 15.9.1. Pricing Analysis 15.9.2. Market Share Analysis, 2022 15.9.2.1. By Dosage Form 15.9.2.2. By Product 15.10. India 15.10.1. Pricing Analysis 15.10.2. Market Share Analysis, 2022 15.10.2.1. By Dosage Form 15.10.2.2. By Product 15.11. Malaysia 15.11.1. Pricing Analysis 15.11.2. Market Share Analysis, 2022 15.11.2.1. By Dosage Form 15.11.2.2. By Product 15.12. Singapore 15.12.1. Pricing Analysis 15.12.2. Market Share Analysis, 2022 15.12.2.1. By Dosage Form 15.12.2.2. By Product 15.13. Thailand 15.13.1. Pricing Analysis 15.13.2. Market Share Analysis, 2022 15.13.2.1. By Dosage Form 15.13.2.2. By Product 15.14. China 15.14.1. Pricing Analysis 15.14.2. Market Share Analysis, 2022 15.14.2.1. By Dosage Form 15.14.2.2. By Product 15.15. Japan 15.15.1. Pricing Analysis 15.15.2. Market Share Analysis, 2022 15.15.2.1. By Dosage Form 15.15.2.2. By Product 15.16. South Korea 15.16.1. Pricing Analysis 15.16.2. Market Share Analysis, 2022 15.16.2.1. By Dosage Form 15.16.2.2. By Product 15.17. Australia 15.17.1. Pricing Analysis 15.17.2. Market Share Analysis, 2022 15.17.2.1. By Dosage Form 15.17.2.2. By Product 15.18. New Zealand 15.18.1. Pricing Analysis 15.18.2. Market Share Analysis, 2022 15.18.2.1. By Dosage Form 15.18.2.2. By Product 15.19. GCC Countries 15.19.1. Pricing Analysis 15.19.2. Market Share Analysis, 2022 15.19.2.1. By Dosage Form 15.19.2.2. By Product 15.20. South Africa 15.20.1. Pricing Analysis 15.20.2. Market Share Analysis, 2022 15.20.2.1. By Dosage Form 15.20.2.2. By Product 15.21. Israel 15.21.1. Pricing Analysis 15.21.2. Market Share Analysis, 2022 15.21.2.1. By Dosage Form 15.21.2.2. By Product 16. Market Structure Analysis 16.1. Competition Dashboard 16.2. Competition Benchmarking 16.3. Market Share Analysis of Top Players 16.3.1. By Regional 16.3.2. By Dosage Form 16.3.3. By Product 17. Competition Analysis 17.1. Competition Deep Dive 17.1.1. Ashland 17.1.1.1. Overview 17.1.1.2. Product Portfolio 17.1.1.3. Profitability by Market Segments 17.1.1.4. Sales Footprint 17.1.1.5. Strategy Overview 17.1.1.5.1. Marketing Strategy 17.1.2. Glanbia plc 17.1.2.1. Overview 17.1.2.2. Product Portfolio 17.1.2.3. Profitability by Market Segments 17.1.2.4. Sales Footprint 17.1.2.5. Strategy Overview 17.1.2.5.1. Marketing Strategy 17.1.3. Herbalife International of America, Inc. 17.1.3.1. Overview 17.1.3.2. Product Portfolio 17.1.3.3. Profitability by Market Segments 17.1.3.4. Sales Footprint 17.1.3.5. Strategy Overview 17.1.3.5.1. Marketing Strategy 17.1.4. Biotrex Nutraceuticals 17.1.4.1. Overview 17.1.4.2. Product Portfolio 17.1.4.3. Profitability by Market Segments 17.1.4.4. Sales Footprint 17.1.4.5. Strategy Overview 17.1.4.5.1. Marketing Strategy 17.1.5. Martínez Nieto 17.1.5.1. Overview 17.1.5.2. Product Portfolio 17.1.5.3. Profitability by Market Segments 17.1.5.4. Sales Footprint 17.1.5.5. Strategy Overview 17.1.5.5.1. Marketing Strategy 17.1.6. Menadiona 17.1.6.1. Overview 17.1.6.2. Product Portfolio 17.1.6.3. Profitability by Market Segments 17.1.6.4. Sales Footprint 17.1.6.5. Strategy Overview 17.1.6.5.1. Marketing Strategy 17.1.7. NUTRASCIENCE LABS 17.1.7.1. Overview 17.1.7.2. Product Portfolio 17.1.7.3. Profitability by Market Segments 17.1.7.4. Sales Footprint 17.1.7.5. Strategy Overview 17.1.7.5.1. Marketing Strategy 17.1.8. NUTRIVO 17.1.8.1. Overview 17.1.8.2. Product Portfolio 17.1.8.3. Profitability by Market Segments 17.1.8.4. Sales Footprint 17.1.8.5. Strategy Overview 17.1.8.5.1. Marketing Strategy 17.1.9. American Health Foundations, INC. 17.1.9.1. Overview 17.1.9.2. Product Portfolio 17.1.9.3. Profitability by Market Segments 17.1.9.4. Sales Footprint 17.1.9.5. Strategy Overview 17.1.9.5.1. Marketing Strategy 17.1.10. Gemini Pharmaceutical 17.1.10.1. Overview 17.1.10.2. Product Portfolio 17.1.10.3. Profitability by Market Segments 17.1.10.4. Sales Footprint 17.1.10.5. Strategy Overview 17.1.10.5.1. Marketing Strategy 17.1.11. Biovencer Healthcare Pvt Ltd 17.1.11.1. Overview 17.1.11.2. Product Portfolio 17.1.11.3. Profitability by Market Segments 17.1.11.4. Sales Footprint 17.1.11.5. Strategy Overview 17.1.11.5.1. Marketing Strategy 17.1.12. Rain Nutrience 17.1.12.1. Overview 17.1.12.2. Product Portfolio 17.1.12.3. Profitability by Market Segments 17.1.12.4. Sales Footprint 17.1.12.5. Strategy Overview 17.1.12.5.1. Marketing Strategy 18. Assumptions & Acronyms Used 19. Research Methodology
Explore Healthcare Insights
View Reports
Nutraceutical Contract Manufacturing Services Market
